(Q38237724)

31 August 2017

Therapeutic potential of nanocarrier for overcoming to P-glycoprotein (English)

1 reference

31 August 2017

1 reference

Vimratjeet Kaur

1

1 reference

31 August 2017

Tarun Garg

series ordinal

2

1 reference

31 August 2017

Goutam Rath

series ordinal

3

1 reference

31 August 2017

Amit K Goyal

series ordinal

4

1 reference

31 August 2017

7 August 2014

1 reference

Journal of Drug Targeting

31 August 2017

1 reference

31 August 2017

22

1 reference

31 August 2017

10

1 reference

31 August 2017

859-870

1 reference

Drug delivery systems: An updated review

31 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

By-passing of P-glycoprotein using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Classification analysis of P-glycoprotein substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

The P-glycoprotein multidrug transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Role of P-glycoprotein in distribution of nelfinavir across the blood-mammary tissue barrier and blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

The mechanism of action of multidrug-resistance-linked P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Overview of P-glycoprotein inhibitors: a rational outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Nanomedicinal strategies to treat multidrug-resistant tumors: current progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Multidrug resistance reversal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Waltzing transporters and 'the dance macabre' between humans and bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

The effect of verapamil on the pharmacokinetics of adriamycin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

A Phase I study of infusional vinblastine in combination with the P-glycoprotein antagonist PSC 833 (valspodar).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Pharmacological strategies for overcoming multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Physicochemical, pharmaceutical and biological approaches toward designing optimized and efficient hydrophobically modified chitosan-based polymeric micelles as a nanocarrier system for targeted delivery of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Dual agent loaded PLGA nanoparticles enhanced antitumor activity in a multidrug-resistant breast tumor eenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Intracellular targeting of polymer-bound drugs for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Nanogels as pharmaceutical carriers: finite networks of infinite capabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Polymeric micelles - a new generation of colloidal drug carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Poly(styrene oxide)-poly(ethylene oxide) block copolymers: From "classical" chemotherapeutic nanocarriers to active cell-response inducers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Biomaterial-based scaffolds--current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Development of chitosan-SLN microparticles for chemotherapy: in vitro approach through efflux-transporter modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Development and evaluation of a novel microemulsion formulation of elacridar to improve its bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

A novel doxorubicin-mitomycin C co-encapsulated nanoparticle formulation exhibits anti-cancer synergy in multidrug resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

Emerging applications of nanoparticles for lung cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.947295

10.3109/1061186X.2014.947295

21 January 2018

Identifiers

DOI

1 reference

31 August 2017

1 reference